AI assistant
Sending…
LABCORP HOLDINGS INC. — Director's Dealing 2022
Mar 31, 2022
30237_dirs_2022-03-31_b70e7f7f-ac21-4062-9bb3-ac9627361565.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2022-03-29
Reporting Person: Schroeder Mark S (EVP, President-Diagnostics Lab)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-29 | Common Stock | S | 2356 | $277.11 | Disposed | 6605.4989 | Direct |
Footnotes
F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
More from LABCORP HOLDINGS INC.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 4
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30